Tag: Hormone Replacement Therapy
Hormone Therapy Not Linked to Lung Cancer in Postmenopausal Women
In subgroup analyses, lower risk was seen with cumulative dosage of ≥401 mg or with therapy duration of five years or longer
Systemic Hormone Therapy During Menopause May Up Risk for Depression
Initiating systemic hormone therapy before age 50 years linked to increased risk for depression
Odds of COVID-19 Mortality Lower for Women Receiving HRT
Receiving hormone replacement therapy within six months of recorded COVID-19 diagnosis linked to reduction in mortality
USPSTF Advises Against Hormone Therapy to Prevent Chronic Conditions
USPSTF recommends against hormone therapy for primary prevention of chronic conditions in postmenopausal persons
FDA Approves First Oral Hormone Therapy for Advanced Prostate Cancer
Phase 3 trial data show 96.7 percent of patients who received Orgovyx achieved and maintained castrate levels of testosterone
Female Hormone Rx Not Tied to Retinal Vascular Occlusion
No increase seen in risk for occlusion of retinal artery, vein among women filling prescription for female hormone therapy
Factors Tied to Hormone Therapy Use After Oophorectomy ID’d
Age, education, preventive mastectomy linked to hormone therapy use in BRCA mutation carriers
Hormone Therapies Tied to Brain Changes in Menopausal Women
Circulating levels of pituitary-ovarian hormones linked to changes in WMH in menopausal women
Reproductive Health Guidelines Issued for Rheumatic Diseases
Evidence reviewed for contraception, fertility, pregnancy, HRT, medication use in RMD patients
Longer Hormone Therapy Tied to Less Muscle Loss in Menopause
In large study of postmenopausal women, sarcopenia lower in participants with history of prolonged HT
